scholarly journals 5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial

Cancer ◽  
2015 ◽  
Vol 121 (15) ◽  
pp. 2537-2543 ◽  
Author(s):  
Nina D. Wagner-Johnston ◽  
Jeff A. Sloan ◽  
Heshan Liu ◽  
Ann E. Kearns ◽  
Stephanie L. Hines ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Randomized Controlled Trial ◽  
Zoledronic Acid ◽  
Bone Loss ◽  
Postmenopausal Women ◽  
Controlled Trial ◽  
Randomized Controlled ◽  
Prevention Of Bone Loss

One-year psoas training can prevent lumbar bone loss in postmenopausal women: A randomized controlled trial

1993 ◽  
Vol 53 (5) ◽  
pp. 307-311 ◽  
Author(s):  
M. Revel ◽  
M. A. Mayoux-Benhamou ◽  
J. P. Rabourdin ◽  
F. Bagheri ◽  
C. Roux
Keyword(s):  
Randomized Controlled Trial ◽  
Bone Loss ◽  
Postmenopausal Women ◽  
Controlled Trial ◽  
Randomized Controlled ◽  
One Year
Sign in / Sign up

Export Citation Format

Share Document